Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

24 Jun 2025 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals Launches TEVIMBRA® in India: Expanding Access to Innovative ImmunoOncology Treatment for Non-Small Cell Lung Cancer and Esophageal Squamous Cell Carcinoma’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..